Su Aung

TL;DR: A synthesis of the current literature pertaining to factors predictive of COVID‐19 clinical course and outcomes shows findings associated with increased disease severity and/or mortality include age, multiple pre‐existing comorbidities, hypoxia, specific computed tomography findings indicative of extensive lung involvement, diverse laboratory test abnormalities, and biomarkers of end‐organ dysfunction.

TL;DR: To better understand the impact of the coronavirus disease 2019 (COVID‐19) pandemic on persons with HIV and improve their care, an outpatient and inpatient clinical experience of HIV/SARS‐CoV‐2 coinfection from Rhode Island, US is presented.

TL;DR: This case presents an elderly female who arrived to the hospital after a syncopal episode and tested positive for COVID-19, underscoring the increasing diversity of CO VID-19 presentations and potential for initial mis- diagnosis and delay in implementing proper precautions.

TL;DR: Patients on remdesivir had lower, albeit not significant, all-cause in-hospital mortality, and the use of remdesvir did not increase the risk for AKI.

TL;DR: No clear clinical benefit associated with HCQ use in COVID-19 patients was found and antimicrobial stewardship programmes can allow for the safe evaluation of agents and treatments against CO VID-19.